Tang Capital Management’s Inhibrx INBX Stock Holding History

Tang Capital Management’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-167,500	Closed	-$2.37M	–	159
2024 Q2	$2.37M	Buy	+167,500	New	+$2.62M	0.24%	74

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tang Capital Management's INBX Position: Q3 2024 in Review

Tang Capital Management sold out of Inhibrx (INBX) in Q3 2024, closing a stake of 167,500 shares — an estimated $2.37M sold.

Tang Capital Management first reported a position in INBX in Q2 2024 and held it in 1 quarter. The position peaked at $2.37M in Q2 2024. 96 funds tracked by Wall St. Rank hold INBX as of Q3 2024.

Tang Capital Management reported no remaining Inhibrx position as of Q3 2024 after selling out during the quarter.
Tang Capital Management sold 167,500 Inhibrx shares in Q3 2024, an estimated $2.37M.
Tang Capital Management first reported a position in Inhibrx in Q2 2024 and held it in 1 quarter.
Tang Capital Management's Inhibrx position peaked at $2.37M in Q2 2024.
96 funds tracked by Wall St. Rank held Inhibrx as of Q3 2024.

Based on Tang Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.